Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

bioAffinity Technologies (BIAF) Receivables - Net (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Receivables - Net for 4 consecutive years, with $541962.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 52.43% to $541962.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $541962.0 through Dec 2025, down 52.43% year-over-year, with the annual reading at $541962.0 for FY2025, 52.43% down from the prior year.
  • Receivables - Net for Q4 2025 was $541962.0 at bioAffinity Technologies, up from $448990.0 in the prior quarter.
  • The five-year high for Receivables - Net was $1.6 million in Q2 2024, with the low at $9930.0 in Q3 2022.
  • Average Receivables - Net over 4 years is $685995.6, with a median of $676818.0 recorded in 2023.
  • The sharpest move saw Receivables - Net surged 11062.28% in 2023, then plummeted 73.56% in 2025.
  • Over 4 years, Receivables - Net stood at $10489.0 in 2022, then surged by 7638.34% to $811674.0 in 2023, then skyrocketed by 40.35% to $1.1 million in 2024, then crashed by 52.43% to $541962.0 in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $541962.0, $448990.0, and $421869.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.